Fundamental principles of an anti-VEGF treatment regimen: optimal application of intravitreal anti–vascular endothelial growth factor therapy of macular diseases

BACKGROUND: Intravitreal anti–vascular endothelial growth factor (VEGF) therapy is now considered the gold standard for the treatment of various retinal disorders. As therapy has evolved, so too have the treatment regimens employed by physicians in clinical practice; however, visual outcomes observe...

Descripción completa

Detalles Bibliográficos
Autores principales: Lanzetta, Paolo, Loewenstein, Anat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486551/
https://www.ncbi.nlm.nih.gov/pubmed/28527040
http://dx.doi.org/10.1007/s00417-017-3647-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486551/
https://www.ncbi.nlm.nih.gov/pubmed/28527040
http://dx.doi.org/10.1007/s00417-017-3647-4

Ejemplares similares